Image (2d955155 686d 40cd 898e Df7d760247a5 740 1)
Lamotrigine
Product Images NDC 68071-2873
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68071-2873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)
Images of Lamotrigine tablets from NuCare Pharmaceuticals, Inc. Four different tablets labeled with strengths and identifiers are shown: 25 mg white oval tablet marked 'U 111', 100 mg white triangular tablet marked 'U 112', 150 mg white triangular tablet marked 'U 113', and 200 mg light blue triangular tablet marked 'U 114'.*
Image (2d955155 686d 40cd 898e Df7d760247a5 789 3)
Pdp (68071 2873 6)
Label for Lamotrigine 100 mg tablets from NuCare Pharmaceuticals, Inc. The package contains 60 tablets. The label describes the tablets as trigonal shaped, biconvex, white with 'U' debossed on one side and '112' on the other side. It includes product and lot details, storage instructions, and warnings to keep out of reach of children. Manufactured by Unichem Laboratories Ltd., India.*
Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure of lamotrigine showing a dichlorophenyl group linked to a triazine ring with amino substituents.*
Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A Kaplan-Meier failure probability curve comparing Lamotrigine to Placebo over a period of approximately 100 weeks. The x-axis represents weeks, and the y-axis shows failure probability as a percentage. The curve includes censored data points marked on the graph.*
Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
A Kaplan-Meier survival curve comparing failure probability (%) over weeks between Lamotrigine and placebo groups. The graph shows two lines, one labeled Lamotrigine and the other Placebo, with censored data points indicated. The X-axis represents time in weeks, and the Y-axis shows failure probability percentage.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
